CVS HEALTH CORPORATION (CVS) Return on equity 2016–2025
CVS HEALTH CORPORATION (CVS) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
2.4%FY2025 · since FY2016: 14.4% → 2.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 2.4% | -3.8 pp |
| FY2024 | 6.1% | -4.8 pp |
| FY2023 | 10.9% | +4.9 pp |
| FY2022 | 6.0% | -4.7 pp |
| FY2021 | 10.7% | +0.4 pp |
| FY2020 | 10.3% | -0.0 pp |
| FY2019 | 10.4% | +11.4 pp |
| FY2018 | -1.0% | -18.6 pp |
| FY2017 | 17.6% | +3.1 pp |
| FY2016 | 14.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice